Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0JN8Q
|
||||
| Former ID |
DNC005913
|
||||
| Drug Name |
N-benzoyl-phenylalanyl-glycine-nitrile
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527885] | ||
| Formula |
C18H17N3O2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CC(C(=O)NCC#N)NC(=O)C2=CC=CC=C2
|
||||
| InChI |
1S/C18H17N3O2/c19-11-12-20-18(23)16(13-14-7-3-1-4-8-14)21-17(22)15-9-5-2-6-10-15/h1-10,16H,12-13H2,(H,20,23)(H,21,22)/t16-/m0/s1
|
||||
| InChIKey |
WEIUVZVWLANUJJ-INIZCTEOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [527885] | |
| Cathepsin S | Target Info | Inhibitor | [527885] | ||
| Cathepsin K | Target Info | Inhibitor | [527885] | ||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Activation of Matrix Metalloproteinases | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.